Zivo Bioscience Inc (ZIVO) Gross Profit Margin starting from the third quarter 2025 to third quarter 2024, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Zivo Bioscience Inc   (ZIVO)


Zivo Bioscience Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ZIVO Gross Profit Margin (Sep 30 2025)
Q3 		(Jun 30 2025)
Q2 		(Mar 31 2025)
Q1 		(Dec 31 2024)
Q4 		(Sep 30 2024)
Q3
Y / Y Revenue Change 108.33 %
Seq. Revenue Change 22.89 %
Revenue In Millions $0.07
Gross Profit Margin 32.44 %
Gross Profit Margin Total Ranking # 2460
Gross Profit In Millions $0.02
Y / Y Gross Profit Change 125.27 %
Seq. Gross Profit Change 18.78 %


Commenting Third Quarter 2025 Gross Profit Margin
Zivo Bioscience Inc has managed to improve its Revenue sequentially to $0.07 millions by 22.89 % faster than Gross Profit increase of 18.78 % to $0.02 millions, this led to contraction in Gross Profit Margin to 32.44 %, below company average.


Observing third quarter 2025 results within Biotechnology & Pharmaceuticals industry 33 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from 2412 to 2460.
Learn about Gross Margin
ZIVO's Gross Profit Margin third quarter 2025 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 34
Healthcare Sector # 391
Overall # 2438

Gross Profit Margin Statistics
High Average Low
82.69 % 39.21 % 30 %
(Jun 30 2023)   (Dec 31 2024)


ZIVO Gross Income Trends • More of ZIVO's Profitabilty Ratios • ZIVO Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
ZIVO's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ZIVO's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ZIVO's Competitors
Gross Profit Margin Profit Margin for Zivo Bioscience Inc 's Suppliers
Gross Profit Margin Profit Margin for ZIVO's Customers

You may also want to know
ZIVO's Annual Growth Rates ZIVO's Profitability Ratios ZIVO's Asset Turnover Ratio ZIVO's Dividend Growth
ZIVO's Roe ZIVO's Valuation Ratios ZIVO's Financial Strength Ratios ZIVO's Gross Profit Growth
ZIVO's Roa ZIVO's Inventory Turnover Ratio ZIVO's Growth Rates ZIVO's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 30 2025, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginSep 30 2025 MRQ Gross ProfitSep 30 2025 MRQ Revenue
Zeo Scientifix Inc   84.52 %$ 1.398  Millions$ 1.654  Millions
Halozyme Therapeutics Inc   84.41 %$ 299.022  Millions$ 354.264  Millions
Adaptive Biotechnologies Corporation  80.68 %$ 75.816  Millions$ 93.973  Millions
X4 Pharmaceuticals Inc  80.11 %$ 1.414  Millions$ 1.765  Millions
Gilead Sciences Inc   79.80 %$ 6,200.000  Millions$ 7,769.000  Millions
Moderna Inc   79.63 %$ 809.000  Millions$ 1,016.000  Millions
Ginkgo Bioworks Holdings Inc   78.95 %$ 30.660  Millions$ 38.837  Millions
Vericel Corporation  73.46 %$ 49.585  Millions$ 67.503  Millions
Biogen Inc   73.39 %$ 1,860.300  Millions$ 2,534.700  Millions
Novavax inc   69.49 %$ 48.949  Millions$ 70.445  Millions
Pelthos Therapeutics Inc   68.73 %$ 5.090  Millions$ 7.406  Millions
Scilex Holding Company  68.48 %$ 7.231  Millions$ 10.560  Millions
Coherus Oncology inc   67.84 %$ 7.850  Millions$ 11.571  Millions
Amgen Inc   67.75 %$ 6,475.000  Millions$ 9,557.000  Millions
Xtant Medical Holdings Inc   66.66 %$ 21.992  Millions$ 32.992  Millions
Bio techne Corp  65.75 %$ 188.112  Millions$ 286.112  Millions
Elutia Inc   64.95 %$ 1.853  Millions$ 2.853  Millions
Galaxy Enterprises Inc   60.07 %$ 0.113  Millions$ 0.188  Millions
Adma Biologics Inc   56.60 %$ 75.626  Millions$ 133.626  Millions
Protalix Biotherapeutics inc   53.37 %$ 9.527  Millions$ 17.851  Millions
Repligen Corp  53.24 %$ 100.515  Millions$ 188.805  Millions
Champions Oncology Inc   51.70 %$ 7.773  Millions$ 15.035  Millions
Twist Bioscience Corporation  51.35 %$ 50.837  Millions$ 99.009  Millions
Iovance Biotherapeutics inc   42.96 %$ 28.978  Millions$ 67.455  Millions
Pluri Inc   36.39 %$ 0.115  Millions$ 0.316  Millions
Zivo Bioscience Inc   32.44 %$ 0.021  Millions$ 0.066  Millions
Dyadic International Inc   12.07 %$ 0.141  Millions$ 1.165  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.